Roshan Agarwal

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

Bryan T. Hennessy, Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale et al. · Cancer Research · 2009 · 857 citations · Full text

Medicine, Cancer Biology, Oncology +17

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Helena Earl, Louise Hiller, Anne-Laure Vallier et al. · The Lancet · 2019 · 283 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers

Bryan T. Hennessy, Yiling Lu, Ana M. González-Angulo et al. · Clinical Proteomics · 2010 · 248 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study

Peter Schmid, Yutaka Nagai, Roshan Agarwal et al. · The Lancet · 2009 · 246 citations · Full text

Medicine, Gynecology, Oncology +11

EMA/CO for High-Risk Gestational Trophoblastic Neoplasia: Good Outcomes With Induction Low-Dose Etoposide-Cisplatin and Genetic Analysis

Constantine Alifrangis, Roshan Agarwal, Delia Short et al. · Journal of Clinical Oncology · 2012 · 225 citations · Full text

Medicine, Oncology, Pharmacology +14